CROI 2013: Drug Combo Scores Early Against HCV/HIV
ATLANTA – A protease inhibitor being investigated in patients co-infected with the hepatitis C...
Read More
Author: PWeekly
CROI 2013: VOICE Trial Results
Results from a large-scale HIV prevention trial among African women known as VOICE (Vaginal and...
Read More
CROI 2103: Select CDC Studies of Interest
CDC scientists will be presenting more than 40 abstracts at CROI 2013. Several studies that may be...
Read More
CROI 2013: Very Early Antiretroviral Treatment Limits the Size of HIV Reservoir
Very early antiretroviral treatment may limit the size of the HIV reservoir in adults and...
Read More
CROI 2013: Pre-exposure HIV Prophylaxis Type Doesn’t Matter
ATLANTA — A large study to determine if pre-exposure prophylaxis could prevent HIV transmission...
Read More
CROI 2013: Extra Drug Hikes HCV Regimen’s Efficacy
ATLANTA – Adding an extra drug to a promising hepatitis C (HCV) regimen increased its efficacy –...
Read More
CROI 2013: HIV Drugs Ease Inflammation in ‘Controllers’
ATLANTA – Putting HIV controllers — who ordinarily don’t need therapy — on highly active...
Read More
CROI 2013: ‘Functional Cure’ Seen in HIV-Infected Child
ATLANTA — Researchers reported here that a child born with HIV infection and treated in infancy...
Read More
FDA Approves Osphena for Postmenopausal Women With Pain During Sex
The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women...
Read More
FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors
The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to...
Read More
Kadcyla Approved for Late-Stage Breast Cancer
The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new...
Read More
First Retinal Implant for Rare Genetic Eye Disease
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the...
Read More
Pomalyst Approved for Advanced Multiple Myeloma
The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients...
Read More
ISC 2013: Life Support Withdrawal Questioned in Stroke Patients
More than a third of patients who suffer a major bleeding in the brain and have their life support...
Read More
ISC 2013: Infant, Child Stroke Survivors Prone to Seizures
About one-third of American infants and children who suffer bleeding into brain tissue may later...
Read More
ISC 2013: Stroke Survivors and Suicidal Thoughts
Nearly one in 12 American stroke survivors may have contemplated suicide or wished themselves...
Read More
ISC 2013: Southern Diet Could Raise Stroke Risk
Eating Southern-style foods may be linked to a higher risk of stroke, according to research...
Read More
ISC 2013: Minimally Invasive Surgery for Hemorrhagic Stroke
The Particulars: Currently, there is no specific, evidence-based targeted treatment that has been...
Read MoreISC 2013: A Novel Approach to Treating Stroke Patients
The Particulars: Currently, the only treatment to relieve swelling of the brain caused by a severe ischemic stroke is craniotomy. A novel intravenous formulation of glyburide (RP-1127), a diabetes drug, may prevent such...
Read More